Ftse Mib
36.471,75
0,12%
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
-0,28%
Bitcoin
99.647,17
-1,01%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX NovaBay Pharmaceuticals Inc New (NBY) NovaBay Pharmaceuticals Inc New (NBY) Notizie

NBY

NovaBay Pharmaceuticals (NBY)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:NBY
DataOraFonteTitoloSimboloCompagnia
23/01/202514:13Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
23/01/202514:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:NBYNovaBay Pharmaceuticals Inc New
23/01/202514:00Business WireNovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution ProposalAMEX:NBYNovaBay Pharmaceuticals Inc New
11/01/202500:06Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:NBYNovaBay Pharmaceuticals Inc New
19/12/202412:50Business WireNovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of StockholdersAMEX:NBYNovaBay Pharmaceuticals Inc New
09/12/202412:50Business WireNovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special MeetingAMEX:NBYNovaBay Pharmaceuticals Inc New
22/11/202422:05Business WireNovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
15/11/202414:00Business WireProminent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova BrandAMEX:NBYNovaBay Pharmaceuticals Inc New
08/11/202423:31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
07/11/202422:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
07/11/202422:05Business WireNovaBay Pharmaceuticals Reports Third Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
06/11/202422:05Business WireNovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase PriceAMEX:NBYNovaBay Pharmaceuticals Inc New
29/10/202413:00Business WireNovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLCAMEX:NBYNovaBay Pharmaceuticals Inc New
16/10/202422:19Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionAMEX:NBYNovaBay Pharmaceuticals Inc New
25/09/202423:17Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionAMEX:NBYNovaBay Pharmaceuticals Inc New
23/09/202415:27PR Newswire (US)Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law FirmAMEX:NBYNovaBay Pharmaceuticals Inc New
20/09/202414:30PR Newswire (US)Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay PharmaceuticalsAMEX:NBYNovaBay Pharmaceuticals Inc New
20/09/202414:00Business WireNovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova AssetsAMEX:NBYNovaBay Pharmaceuticals Inc New
13/08/202422:05Business WireNovaBay Pharmaceuticals Reports Second Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
01/08/202412:50Business WireNovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
30/07/202412:50Business WireNovaBay Pharmaceuticals Reports Record Amazon Prime Day SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
29/07/202422:05Business WireNovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment OptionAMEX:NBYNovaBay Pharmaceuticals Inc New
26/07/202423:19Edgar (US Regulatory)Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
26/07/202414:30Business WireNovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public OfferingAMEX:NBYNovaBay Pharmaceuticals Inc New
26/07/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:NBYNovaBay Pharmaceuticals Inc New
16/07/202412:50Business WireNovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime DayAMEX:NBYNovaBay Pharmaceuticals Inc New
11/07/202414:50Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NBYNovaBay Pharmaceuticals Inc New
11/07/202412:50Business WireNovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 MillionAMEX:NBYNovaBay Pharmaceuticals Inc New
10/07/202415:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
28/06/202412:50Business WireNovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product PromotionsAMEX:NBYNovaBay Pharmaceuticals Inc New
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:NBY

La tua Cronologia

BIT
STMMI
ST Microelectronics
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
G
Generali
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
ENEL
Enel
BIT
PRY
Prysmian
BIT
CPR
Davide Campari
BIT
BAMI
Banco BPM
BIT
IVG
Iveco Group NV
BIT
SPM
Saipem
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci